Literature DB >> 22200302

High resolution separation methods for the determination of intact human erythropoiesis stimulating agents. A review.

Michel Girard1, Angel Puerta, Jose Carlos Diez-Masa, Mercedes de Frutos.   

Abstract

Human erythropoietin (hEPO), a hormone involved in the formation of red blood cells, is a 30 kDa glycoprotein with a high carbohydrate content. The production of recombinant hEPO has made possible its widespread therapeutic use and its banned use in competition sports. Methods to analyze EPO and other erythropoiesis stimulating agents (ESAs) are necessary for the characterization and quality control of these biopharmaceuticals and also for doping control. In this paper, high resolution separation methods, namely high performance liquid chromatography (HPLC) and capillary electrophoresis (CE), with special attention to CE-coupled mass spectrometry, are reviewed. The usefulness of these techniques when applied in different modes to separate the glycoprotein isoforms, aggregates or excipients are detailed. In addition, sample preparation methods that have been applied to ESA samples for subsequent determination by HPLC or CE, as well as the potential compatibility of other preparation methods, are discussed. Applications of the HPLC and CE methods regarding regulatory considerations for biopharmaceuticals analysis, with emphasis on biosimilars, and doping control are also included. Finally, limitations of the present methods and their possible solutions are considered.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200302     DOI: 10.1016/j.aca.2011.11.041

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  2 in total

1.  Affinity purification of erythropoietin from cell culture supernatant combined with MALDI-TOF-MS analysis of erythropoietin N-glycosylation.

Authors:  David Falck; Markus Haberger; Rosina Plomp; Michaela Hook; Patrick Bulau; Manfred Wuhrer; Dietmar Reusch
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

2.  Development of a stable chemically cross-linked erythropoietin dimer for use in the quality control of erythropoietin therapeutic products.

Authors:  Paul Matejtschuk; Chinwe Duru; Kiran P Malik; Adrian F Bristow; Angele Costanzo; Chris J Burns
Journal:  Anal Bioanal Chem       Date:  2019-04-10       Impact factor: 4.142

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.